SMS Lifesciences India Limited (NSE:SMSLIFE) — Stock Price
SMS Lifesciences India Limited (NSE:SMSLIFE) is currently trading at Rs1288.50 INR, down 6.64% today. Over the past 52 weeks, shares have ranged between Rs1078.80 and Rs1437.90. This page tracks SMS Lifesciences India Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is SMS Lifesciences India Limited worth.
SMS Lifesciences India Limited (SMSLIFE) Stock Price Chart — Daily History & Trading Volume
The chart below tracks SMS Lifesciences India Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
SMS Lifesciences India Limited Income Statement — Revenue, Profit & Earnings by Year
SMS Lifesciences India Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | Rs3.45 Billion | Rs3.06 Billion | Rs3.16 Billion | Rs3.47 Billion | Rs2.66 Billion |
| Cost of Revenue | Rs2.94 Billion | Rs2.10 Billion | Rs2.28 Billion | Rs2.60 Billion | Rs1.87 Billion |
| Gross Profit | Rs505.79 Million | Rs962.44 Million | Rs875.57 Million | Rs875.42 Million | Rs702.13 Million |
| Research & Development | Rs53.90 Million | Rs45.54 Million | Rs80.16 Million | Rs28.75 Million | Rs19.55 Million |
| SG&A | Rs595.97 Million | Rs33.87 Million | Rs32.40 Million | Rs26.87 Million | Rs31.13 Million |
| Total Operating Expenses | Rs205.36 Million | Rs572.91 Million | Rs664.98 Million | Rs628.88 Million | Rs478.27 Million |
| Operating Income | Rs300.42 Million | Rs359.47 Million | Rs173.38 Million | Rs225.39 Million | Rs246.94 Million |
| EBITDA | Rs498.99 Million | Rs349.41 Million | Rs341.76 Million | Rs489.11 Million | Rs319.58 Million |
| EBIT | Rs349.02 Million | Rs200.03 Million | Rs233.88 Million | Rs389.05 Million | Rs240.97 Million |
| Interest Expense | Rs87.13 Million | Rs101.57 Million | Rs67.95 Million | Rs61.74 Million | Rs45.29 Million |
| Income Before Tax | Rs261.90 Million | Rs98.47 Million | Rs165.93 Million | Rs327.31 Million | Rs195.68 Million |
| Income Tax Expense | Rs74.58 Million | Rs35.19 Million | Rs52.16 Million | Rs74.31 Million | Rs60.11 Million |
| Net Income | Rs201.09 Million | Rs90.93 Million | Rs114.63 Million | Rs253.22 Million | Rs135.57 Million |
SMS Lifesciences India Limited Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes SMS Lifesciences India Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | Rs3.90 Billion | Rs3.91 Billion | Rs3.37 Billion | Rs3.57 Billion | Rs3.02 Billion |
| Total Current Assets | Rs1.51 Billion | Rs1.55 Billion | Rs1.68 Billion | Rs1.56 Billion | Rs1.26 Billion |
| Cash & Equivalents | Rs10.05 Million | Rs9.23 Million | Rs31.35 Million | — | — |
| Short-term Investments | Rs10.05 Million | Rs9.23 Million | Rs8.03 Million | Rs23.70 Million | Rs20.89 Million |
| Net Receivables | Rs687.87 Million | Rs513.50 Million | Rs460.61 Million | Rs338.32 Million | Rs341.50 Million |
| Inventory | Rs673.98 Million | Rs812.10 Million | Rs804.62 Million | Rs848.11 Million | Rs616.32 Million |
| Property, Plant & Equipment | Rs2.32 Billion | Rs2.29 Billion | Rs2.29 Billion | Rs1.93 Billion | Rs1.51 Billion |
| Goodwill | — | Rs87.00K | — | Rs0.00 | Rs169.48 Million |
| Total Liabilities | Rs1.78 Billion | Rs1.97 Billion | Rs1.73 Billion | Rs1.92 Billion | Rs1.73 Billion |
| Total Current Liabilities | Rs1.42 Billion | Rs1.45 Billion | Rs1.11 Billion | Rs1.35 Billion | Rs1.14 Billion |
| Long-term Debt | Rs182.68 Million | Rs331.45 Million | Rs459.70 Million | Rs403.32 Million | Rs391.41 Million |
| Net Debt | Rs849.00 Million | Rs1.00 Billion | Rs868.47 Million | Rs786.11 Million | Rs561.50 Million |
| Total Stockholder Equity | Rs1.97 Billion | Rs1.77 Billion | Rs1.64 Billion | Rs1.52 Billion | Rs1.29 Billion |
| Retained Earnings | Rs1.87 Billion | Rs1.68 Billion | Rs892.08 Million | Rs788.77 Million | Rs600.23 Million |
SMS Lifesciences India Limited Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how SMS Lifesciences India Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | Rs298.10 Million | Rs243.06 Million | Rs1.47K | Rs-112.41 Million | Rs351.70 Million |
| Capital Expenditures | Rs153.49 Million | Rs208.68 Million | Rs4.86K | Rs511.53 Million | Rs355.56 Million |
| Free Cash Flow | Rs144.61 Million | Rs34.38 Million | Rs-3.39K | Rs-623.94 Million | Rs-3.87 Million |
| Investing Cash Flow | Rs-150.61 Million | Rs-184.50 Million | Rs-312.92 Million | Rs-71.43 Million | Rs-262.35 Million |
| Financing Cash Flow | Rs-148.15 Million | Rs-65.64 Million | Rs1.69K | Rs108.33 Million | Rs-25.46 Million |
| Dividends Paid | Rs4.54 Million | Rs4.54 Million | Rs4.54 Million | Rs4.54 Million | Rs4.54 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | Rs149.97 Million | Rs149.38 Million | Rs1.08K | Rs100.06 Million | Rs78.62 Million |
| Change in Cash | Rs156.00K | Rs-7.08 Million | Rs29.19 | Rs-75.50 Million | Rs63.88 Million |
SMS Lifesciences India Limited Earnings History — EPS Actual vs. Analyst Estimates
Track SMS Lifesciences India Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 27, 2026 | — | — | — |
| Feb 10, 2026 | — | — | — |
| Nov 11, 2025 | — | — | — |
| Aug 07, 2025 | — | — | — |
| Feb 08, 2025 | — | — | — |
| Nov 09, 2024 | — | — | — |
| Nov 14, 2019 | 11.56 | 16.91 | -31.64% |